Rasmussen's Encephalitis
Neurol 60:422-425, Granata,T.,et al, 2003
Neuromyelitis Optica:What It Is and What It Might Be
Lancet 361:889-890, Weinshenker,B.G., 2003
Mitoxantrone in Progressive Multiple Sclerosis: A Placebo-Controlled, Double-Blind, Randomised, Multicentre Trial
Lancet 360:2018-2025, Hartung,H.,et al, 2002
Management of Acute Optic Neuritis
Lancet 360:1953-1962, Hickman,S.J.,et al, 2002
Benefit of Interferon B-1a on MSFC Progression in Secondary Progressive MS
Neurol 59:679-687, Cohen,J.A.,et al, 2002
Therapy-Related Acute Myeloblastic Leukemia After Mitoxantrone Treatment in a Patient with MS
Neurol 59:954-955, Brassat,D.,et al, 2002
Application of the New McDonald Criteria to Patients with Clinically Isolated Syndromes Suggestive of Mulitple Sclerosis
Ann Neurol 52:47-53, Dalton,C.M.,et al, 2002
Migraine--Current Understanding and Treatment
NEJM 346:257-270, Goadsby,P.J.,et al, 2002
Euthanasia and Physician-Assisted Suicide Among Patients with Amyotrophic Lateral Sclerosis in the Netherlands
NEJM 346:1638-1644, Veldink,J.H.,et al, 2002
A Practical Approach to the Diagnosis and Management of MELAS: Case Report and Review
The Neurologist 8:302-312, Thambisetty,M.,et al, 2002
The Effect of IFNB-1b on the Evolution of Enhancing Lesions in Secondary Progressive MS
Neurol 57:2185-2190, Brex,P.A.,et al, 2001
Chronic Encephalitis and Temporal Lobe Epilepsy: A Variant of Rasmussen's Syndrome?
Neurol 56:678-681, Hennessy,M.J.,et al, 2001
Positive Response to Immunommodulatory Therapy in an Adult Patient with Rasmussen's Encephalitis
Neurol 56:248-250, Villani,F.,et al, 2001
Spontaneous Dissection of the Carotid and Vertebral Arteries
NEJM 344:898-906, Schievink,W.I., 2001
Spontaneous Intracerebral Hemorrhage
NEJM 344:1450-1460, Qureshi,A.I.,et al, 2001
Clinical and Neuroradiologic Features of Acute Disseminated Encephalomyelitis in Children
Neurol 56:1308-1312,1257, Hynson,J.L.,et al, 2001
Randomized Controlled Trial of Interferon-beta-1a in Secondary Progressive MS
Neurol 56:1496-1504, Secondary Progressive Efficacy Clinical Trial of R, 2001
Randomized Controlled Trial of Interferon-beta-1a in Secondary Progressive MS
Neurol 56:1505-1513, Li,D.K.B.,et al, 2001
Acute, Chronic, and Recurrent Varicella Zoster Virus Neuropathy Without Zoster Rash
Neurol 57:351-354, Fox,R.J.,et al, 2001
Return to Driving After Head Injury
JNNP 70:761-766, Hawley,C.A., 2001
Neuro-Ophthalmic Manifestations of Sarcoidosis. Clincal Spectrum, Evaluation and Management
J Neuroophthalmol 21:132-137, Frohman,L.P,et al, 2001
Relapses and Progression of Disability in Multiple Sclerosis
NEJM 343:1430-1438,1486, Confavreux,C.,et al, 2000
Multifocal Motor Neuropathy Improved by IVIg
Neurol 55:1256-1262,1246, Federico,P.,et al, 2000
A 44-Year-Old Woman with Difficulty Walking
JAMA 284:2632-2639, Iezzoni,L.I., 2000
Topiramate Relieves Refractory Trigeminal Neuralgia in MS Patients
Neurol 55:1587-1588, Zvartau-Hind,M.,et al, 2000
Clinicopath Conf,Wegener's Granulomatosis with Pachymeningeal Granulomatous Inflammation, Case 9-1999
NEJM 340:945-953, , 1999
Fibromyalgia Syndrome a Decade Later
Arch Int Med 159:777-785, Goldenberg,D.L., 1999
Intravenous Immunoglobulin Treatment in Neurologic Disorders
Arch Neurol 56:1025-1027,1032, Sorensen,P.S., 1999
Is the Routine Use of Intravenous Immunoglobulin Treatment in Neurologic Disorders Justified?
Arch Neurol 56:1028-1032, Karussis,D.&Abramsky,O., 1999
Multiple Sclerosis That is Progressive From the Time of Onset, Clinical Characteristics and Progression of Disability
Arch Neurol 56:1138-1142, Andersson,P.B.,et al, 1999
The Clinical Course of Neuromyelitis Optica (Devic's Syndrome)
Neurol 53:1107-1114, Wingerchuk,D.M.,et al, 1999
Population Based Cost Utility Study of Interferon Beta-1b in Secondary Progressive Multiple Sclerosis
BMJ 319:1529-1533, Forbes,R.B.,et al, 1999
Intravenous Immunoglobulin in the Treatment of Autoimmune Neuromuscular Diseases:Present Status and Practical Therapeutic Guidelines
Muscle & Nerve 22:1479-1497, Dalakas,M.C., 1999
Early Diagnosis of Central Nervous System Aspergillosis With Combination Use of Cerebral Diffusion-Weighted Echo-Planar Magnetic Resonance Image and Polymerase Chain Reaction of Cerebrospinal Fluid
Internal Medicine 38:45-48, Kami,M.,et al, 1999
An Open-Label Trial of Gabapentin Treatment of Paroxysmal Symptoms in Multiple Sclerosis Patients
Neurol 51:609-611, Solaro,C.,et al, 1998
Gabapentin Relieves Trigeminal Neuralgia in Multiple Sclerosis Patients
Neurol 51:611-614, Khan,O.A., 1998
Clinicopath Conf
Subacute Sclerosing Panencephalitis, Case 15-1998, NEJM 338:1448-1456998., , 1998
Use of Corticosteroids in Multiple Sclerosis by Consultant Neurologists in the United Kingdom
JNNP 54:362-365, Tremlett,H.L.,et al, 1998
Cerebral Amyloid Angiopathy:Propsects for Clinical Diagnosis and Treatment
Neurol 52:690-694, Greenberg,S.M., 1998
Second Malig in Young Children with Prim Brain Tumors Following Trtm with Prolonged Postop Chemo & Delay Irrad
Ann Neurol 44:313-316, 3001998., Duffner,P.K.,et al, 1998
Placebo-Controlled Multicentre Randomised Trial of Interferon B-1b in Treatment of Secondary Progressive Multiple Sclerosis
Lancet 352:1491-1497,1486, European Study Group on Interferon B-1b in Seconda, 1998
Clinical Approach to Inherited Peroxisomal Disorders: A Series of 27 Patients
Ann Neurol 44:720-730,713, Baumgartner,M.R.,et al, 1998
Adult Brainstem Gliomas
Neurol 51:1136-1139, Landolfi,J.C.,et al, 1998
Long-Term Outcomes after Radiosurgery for Acoustic Neuromas
NEJM 339:1426-1433,1471, Kondziolka,D.,et al, 1998
Retinocochleocerebral Vasculopathy
Medicine 77:12-40, Petty,G.W.,et al, 1998
Diagnostic Aspects of Narcolepsy
Neurol 50:S2-S7, Aldrich,M.S., 1998
Small-Vessel Vasculitis
NEJM 337:1512-1523, Jennette,J.C.&Falk,R.J., 1997
Idiopathic Granulomatous Angiitis of the CNS Manifesting as Diffuse White Matter Disease
Neurol 49:1696-1699, Finelli,P.F.,et al, 1997
Management of Multiple Sclerosis
NEJM 337:1604-1611, Rudick,R.A.,et al, 1997
Herpes Simplex Encephalitis Treated with Acyclovir:Diagnosis and Long Term Outcome
JNNP 63:321-326, McGrath,N.,et al, 1997